Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
VALE
Vale
$9.13
Chart
$9.11 (+0.22%)
$9.9 (-7.78%)
$8.89 (+2.70%)
$11.26 (-18.92%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
VALE
Vale
Current Price
$9.13
Login to view Vale (VALE) recommendation from the last 90 days from financial news and social media.
Chart
$9.11 (+0.22%)
$9.9 (-7.78%)
$8.89 (+2.70%)
$11.26 (-18.92%)
VALE Latest Headlines
Kruse GWS Auctions Putting on the Ritz with Hollywood Memorabilia Auction. Kruse GWS Auction'.s Making History Again with Hollywood Artifacts and Celebrity Memorabilia a Stage Set to Fetch Hundreds of ThousandsBeverly Hills CA May 30 2025 --()-- Kruse GWS Auctions is “.Putting on the Ritz”. With Upcoming Hollywood Memorabilia Auction featuring Steve McQueen’.s Mini Trail Motorcycle Ashton Kutcher’.s Sunnyvale Robe Nicolas Cage’.s Boots Michael Jackson’.s 1970 Ho
Today
Kruse GWS Auctions Putting on the Ritz with Hollywood Memorabilia Auction. Kruse GWS Auction'.s Making History Again with Hollywood Artifacts and Celebrity Memorabilia a Stage Set to Fetch Hundreds of ThousandsBeverly Hills CA May 30 2025 --()-- Kruse GWS Auctions is “.Putting on the Ritz”. With Upcoming Hollywood Memorabilia Auction featuring Steve McQueen’.s Mini Trail Motorcycle Ashton Kutcher’.s Sunnyvale Robe Nicolas Cage’.s Boots Michael Jackson’.s 1970 Ho
Today
Exclusive-Miner Vale misses deadline for power to expand Brazil nickel complex.
Today
Revalesio Presents Additional Analyses from the Phase 2 RESCUE Clinical Trial for RNS60 in Acute Ischemic Stroke. TACOMA Wash. May 21 2025 /PRNewswire/ -- Revalesio a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders today announced data from a post hoc analysis of its completed Phase 2 RESCUE clinical trial showing that ischemic stroke...
Wed May 21, 2025
VALE Quantitative Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for VALE SA (ADR) (VALE). Of the 22 guru strategies we follow VALE rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative
Tue May 20, 2025
VALE Quantitative Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for VALE SA (ADR) (VALE). Of the 22 guru strategies we follow VALE rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative
Tue May 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VALE Stock trends
VALE Stock performance
VALE Stock analysis
VALE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
